FdaApplication
ANDA 217049
Identifiers
- fda_app_no: ANDA217049
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS PHARMS USA INC |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 12.5MG;2.5MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 25MG;5MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 10MG;5MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | 5MG;2.5MG;1000MG | TABLET, EXTENDED RELEASE;ORAL |
4 products